Anika Therapeutics Contracts & Agreements

Cooperation Agreement, dated May 28, 2024, by and among the Company and the Investor Group (Filed With SEC on May 28, 2024)

Offer letter dated as of May 2, 2024 between Anika Therapeutics, Inc. and Stephen Griffin (Filed With SEC on May 8, 2024)

Executive Retention Agreement effective as of June 3, 2024 between Anika Therapeutics, Inc. and Stephen Griffin (Filed With SEC on May 8, 2024)

Transitional Services and Separation Agreement dated as of May 2, 2024 between Anika Therapeutics, Inc. and Michael Levitz (Filed With SEC on May 8, 2024)

Anika Therapeutics, Inc. Non-Employee Director Compensation Policy (restated as of December 22, 2023) (Filed With SEC on March 15, 2024)

Executive Retention Agreement, dated September 27, 2021, by and between Anika Therapeutics, Inc. and Anne Nunes (Filed With SEC on March 15, 2024)

Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (as amended effective June 14, 2023) (Filed With SEC on June 21, 2023)

Cooperation Agreement, dated April 13, 2023, by and among the Company and the Investor Group (Filed With SEC on April 13, 2023)

Description of Securities of Anika Therapeutics, Inc (Filed With SEC on March 16, 2023)

Executive Retention Agreement, dated March 9, 2020, by and between Anika Therapeutics, Inc. and David Colleran (Filed With SEC on March 16, 2023)

Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (as amended effective June 8, 2022) (Filed With SEC on June 10, 2022)

Lease Agreement, dated November 26, 2012, between High Properties and Parcus Medical LLC relating to 6423 Parkland Drive, Suites 101 and 102, Sarasota, FL (Filed With SEC on March 11, 2022)

Amendment #1 to the Lease, Renewal Amendement, dated January 4, 2018, between High Properties and Parcus Medical LLC relating to 6423 Parkland Drive, Suites 101 and 102, Sarasota,... (Filed With SEC on March 11, 2022)

Lease Agreement, dated May 25, 2017, between High Properties and Parcus Medical, LLC relating to 6455 Parkland Drive, Suite 101, Sarasota, FL (Filed With SEC on March 11, 2022)

Anika Therapeutics, Inc. Non-Employee Director Compensation Policy (restated as of February 9, 2022) (Filed With SEC on March 11, 2022)

Form of Notice of Grant of Nonqualified Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on March 11, 2022)

Form of Notice of Grant of Restricted Stock Units Award, including Terms and Conditions of Restricted Stock Award, granted under Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on March 11, 2022)

Form of Notice of Grant of Deferred Stock Awards Units, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on March 11, 2022)

Executive Retention Agreement, dated August 10, 2020, by and between Anika Therapeutics, Inc. and Michael Levitz (Filed With SEC on March 11, 2022)

Anika Therapeutics, Inc. 2021 Inducement Plan (Filed With SEC on November 5, 2021)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on November 5, 2021)

Form of Notice of Grant of Incentive Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Form of Notice of Grant of Nonqualified Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Form of Notice of Grant of Restricted Stock Units, including Terms and Conditions of Restricted Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Form of Notice of Grant of Deferred Stock Awards Units, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)

Offer letter dated as of July 29, 2020 between Anika Therapeutics, Inc. and Michael Levitz (Filed With SEC on August 5, 2020)

First Amendment effective August 13, 2019, with respect to the Credit Agreement dated as of October 24, 2017 and the Security and Pledge Agreement dated as of October 24, 2017 (Filed With SEC on May 22, 2020)

Second Amendment effective May 14, 2020, with respect to the Credit Agreement dated as of October 24, 2017 and the Security and Pledge Agreement dated as of October 24, 2017 (Filed With SEC on May 22, 2020)

Employment Agreement dated as of April 23, 2020 between Anika Therapeutics, Inc. and Cheryl R. Blanchard (Filed With SEC on April 29, 2020)

Form of Notice of Grant of Deferred Stock AwardsUnits, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 6, 2020)

Letter agreement dated February 25, 2020, between Anika Therapeutics, Inc. and Cheryl R. Blanchard (Filed With SEC on March 2, 2020)

Agreement and Plan of Merger, dated January 4, 2020, by and between Anika Therapeutics, Inc., Arthrosurface, Inc., Button Merger Sub, Inc. and Boston Millennia Partners Button... (Filed With SEC on January 7, 2020)

Agreement and Plan of Merger, dated January 4, 2020, by and between Anika Therapeutics, Inc., Parcus Medical, LLC, Sunshine Merger Sub, LLC and Philip Mundy (Filed With SEC on January 7, 2020)

Fixed Dollar Accelerated Share Repurchase Transaction, dated May 7, 2019, by and between Anika Therapeutics, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on July 26, 2019)

Separation Agreement, effective July 8, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn, Ph.D (Filed With SEC on July 10, 2019)

Consulting Agreement, effective July 5, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn, Ph.D (Filed With SEC on July 10, 2019)

Amendment No. 2, dated April 9, 2019, to Employment Agreement, dated July 27, 2017, as amended March 8, 2018, by and between Anika Therapeutics, Inc. and Joseph G. Darling (Filed With SEC on April 12, 2019)

Amendment No. 2, dated April 9, 2019, to Employment Agreement, dated March 22, 2010, as amended December 8, 2010, by and between Anika Therapeutics, Inc. and Sylvia Cheung (Filed With SEC on April 12, 2019)

Executive Retention Agreement, dated April 9, 2019, by and between Anika Therapeutics, Inc. and Thomas Finnerty (Filed With SEC on April 12, 2019)

Executive Retention Agreement, dated April 9, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn (Filed With SEC on April 12, 2019)

Fixed Dollar Accelerated Share Repurchase Transaction Confirmation entered into as of May 24, 2018 by and between Morgan Stanley & Co. LLC and Anika Therapeutics, Inc (Filed With SEC on July 31, 2018)

Plan of Domestication of Anika Therapeutics, Inc., as adopted by Anika Therapeutics, Inc. on March 23, 2018 and approved by the stockholders of Anika Therapeutics, Inc. on May 31,... (Filed With SEC on June 6, 2018)

Consulting Agreement between Anika Therapeutics, Inc. and Charles H. Sherwood, Ph.D. dated March 8, 2018 (Filed With SEC on March 8, 2018)

Amendment No. 1 dated March 8, 2018 to Employment Agreement dated July 27, 2017 by and between Anika Therapeutics, Inc. and Joseph G. Darling (Filed With SEC on March 8, 2018)

EMPLOYMENT AGREEMENT (Filed With SEC on July 27, 2017)

NEGOTIATED SETTLEMENT AGREEMENT AND GENERAL RELEASE (Filed With SEC on July 14, 2017)

Farley White Wiggins, LLC c/o Farley White Interests 155 Federal Street, Suite 1200 Boston, MA 02110 (Filed With SEC on February 24, 2017)

AMENDMENT TO THE LEASE CONTRACT OF A FUTURE BUILDING between (Filed With SEC on February 24, 2017)

EXHIBIT A TOLLING AGREEMENT AMENDMENT Between (Filed With SEC on February 24, 2017)

Fixed Dollar Accelerated Share Repurchase Transaction (Filed With SEC on May 3, 2016)

LEASE AMENDMENT AGREEMENT Between (Filed With SEC on May 3, 2016)

AMENDMENT TO THE LEASE AGREEMENT (Reg.ne 39 series 3T) By and between (Filed With SEC on May 3, 2016)

AMENDMENT TO THE LEASE AGREEMENT (Reg. 39 series 3T) Between (Filed With SEC on May 3, 2016)

Anika Therapeutics, Inc. Consulting Agreement (Filed With SEC on December 9, 2015)

By: /s/ Steven Cyr for Charles H. SherwoodNovember 18, 2014Charles H. Sherwood, Ph.D.DateChief Executive Officer (Filed With SEC on March 13, 2015)

DIRECTORINDEMNIFICATION AGREEMENT (Filed With SEC on November 6, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on May 5, 2014)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 5, 2014)

AMENDMENT TO ANIKA THERAPEUTICS,INC. SECOND AMENDED AND RESTATED 2003 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on June 21, 2013)

By:/s/ Charles H. SherwoodFebruary 1, 2013Charles H. Sherwood, Ph.DDateChief Executive Officer (Filed With SEC on February 28, 2013)

LICENSE AGREEMENT between ANIKA THERAPEUTICS, INC. and DEPUY MITEK, INC. (Filed With SEC on December 22, 2011)

EXHIBIT 10.1 ANIKA THERAPEUTICS,INC. (Filed With SEC on June 10, 2011)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2011)

Exhibit 10.1 ___________________________________________________ PLEDGE AGREEMENT ON A QUOTA OF FIDIA ADVANCED BIOPOLYMERS S.r.l.... (Filed With SEC on May 10, 2010)

___________________________________________________ PLEDGE AGREEMENT ON A QUOTA OF FIDIA ADVANCED BIOPOLYMERS S.r.l. ___________________________________________________ (Filed With SEC on March 16, 2010)

________________________________________________ Saleand Purchase Agreement byand between FidiaFarmaceutici S.p.A. asseller and AnikaTherapeutics Inc. asbuyer... (Filed With SEC on January 6, 2010)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on January 6, 2010)

FIDIA FARMACEUTICI S.PA. and FIDIA ADVANCED BIOPOLYMERS S.R.L. (Filed With SEC on January 6, 2010)

FIDIA FARMACEUTICI S.P.A. AND FIDIA ADVANCED BIOPOLYMERS S.R.L. (Filed With SEC on January 6, 2010)

CONSENTAND FIRST AMENDMENT (Filed With SEC on January 6, 2010)

RESTRICTED DEFERRED STOCK UNIT AWARD AGREEMENT UNDER THE ANIKA THERAPEUTICS, INC. 2003 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 9, 2009)

EXHIBIT10.1 EMPLOYMENTAGREEMENT (Filed With SEC on October 22, 2008)

EXHIBIT10.2 EMPLOYMENTAGREEMENT (Filed With SEC on October 22, 2008)

CREDIT AGREEMENT Dated as of January 31, 2008 among ANIKATHERAPEUTICS, INC. as Borrower, ANIKASECURITIES, INC. as aGuarantor, BANK OF AMERICA, N.A., as Administrative Agent, and... (Filed With SEC on February 6, 2008)

ANIKA THERAPEUTICS, INC. SENIOR EXECUTIVE INCENTIVE COMPENSATION PLAN (Filed With SEC on February 6, 2008)

FORM OFPERFORMANCE SHARE AWARD AGREEMENT UNDER THEANIKA THERAPEUTICS, INC. 2003 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on February 6, 2008)

DATE OF LEASE EXECUTION: January 3, 2007 (Filed With SEC on January 10, 2007)

LICENSE ANDDEVELOPMENT AGREEMENT between ANIKATHERAPEUTICS, INC. and GALDERMAPHARMA S.A. (Filed With SEC on August 7, 2006)

SUPPLY AGREEMENT among GALDERMA S.A. GALDERMA PHARMA S.A. and ANIKA THERAPEUTICS,INC. (Filed With SEC on August 7, 2006)

STOCKAPPRECIATION RIGHT AGREEMENT (For Stock-Settled SARs) UNDERANIKA THERAPEUTICS, INC. 2003 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on May 9, 2006)

STOCKAPPRECIATION RIGHT AGREEMENT FOR NON-EMPLOYEE DIRECTORS (For Stock-Settled SARs) UNDERANIKA THERAPEUTICS, INC. 2003 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on May 9, 2006)

ANIKA THERAPEUTICS, INC. (Filed With SEC on July 12, 2005)

ANIKA THERAPEUTICS, INC. Form of Change in Control, Bonusand Severance Agreement (Filed With SEC on November 19, 2004)

ANIKA THERAPEUTICS, INC. (Filed With SEC on October 5, 2004)

INCENTIVE STOCK OPTION AGREEMENT UNDER THE ANIKA THERAPEUTICS, INC. 2003 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on October 5, 2004)

NON-QUALIFIED STOCK OPTIONAGREEMENT FOR COMPANY NON-EMPLOYEE DIRECTORS UNDER THE ANIKA THERAPEUTICS,INC. 2003 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on October 5, 2004)

LICENSE AGREEMENT between ANIKA THERAPEUTICS, INC. and ORTHO-MCNEILPHARMACEUTICAL, INC. acting through its ORTHONEUTROGENA DIVISION (Filed With SEC on August 16, 2004)

CUMMINGS PROPERTIES, LLC STANDARD FORM LEASE EXTENSION (Filed With SEC on November 14, 2003)

AMENDMENT (Filed With SEC on November 14, 2003)

ANIKA THERAPEUTICS, INC. Form ofChange in Control, Bonus and Severance Agreement (Filed With SEC on August 14, 2003)

[Anika Therapeutics, Inc. Letterhead] (Filed With SEC on May 15, 2003)

ANIKA THERAPEUTICS, INC. (Filed With SEC on May 15, 2003)

AGREEMENT OF SUBSTITUTION AND AMENDMENT OF SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on November 14, 2002)

[ANIKA THERAPEUTICSLETTERHEAD] April 2, 2002 (Filed With SEC on August 14, 2002)

[ANIKA THERAPEUTICS LETTERHEAD] (Filed With SEC on August 14, 2002)

ANIKATHERAPEUTICS, INC. Changein Control, Bonus and Severance Agreement (Filed With SEC on August 14, 2002)

ANIKATHERAPEUTICS, INC. FirstAmended and Restated Changein Control, Bonus and Severance Agreement (Filed With SEC on August 14, 2002)

SUBLEASE (Filed With SEC on May 15, 2002)

Category

Industry

Companies

Contracts

Anika Therapeutics Contracts & Agreements